Showing results (491-500 of 518) with videos related to

Sort By:
Pageof 52
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Communications Medicine|March 2, 2025
The radiogenomic and spatiogenomic landscapes of glioblastoma and their relationship to oncogenic driversAnahita Fathi Kazerooni, Hamed Akbari, Xiaoju Hu, et al.
Science (New York, N.Y.)|October 2, 2020
Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tauNabil F Darwich, Jessica M Phan, Boram Kim, et al.
International Journal of Molecular Sciences|May 25, 2024
Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and VaccinationEmma J Leacy, Jia Wei Teh, Aoife M O'Rourke, et al.
Molecular Therapy Oncolytics|October 12, 2018
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine GliomasYibo Yin, Alina C Boesteanu, Zev A Binder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II TrialDavid A Reardon, Annick Desjardins, James J Vredenburgh, et al.
The Journal of Pathology|June 1, 2026
CLEC14A correlates with neutrophil infiltration in hepatocellular carcinoma and mediates neutrophil recruitment across liver endothelial cellsJoanne M O'Rourke, Dean Kavanagh, Ayla O'Keeffe, et al.
Cell|December 30, 2019
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral HeterogeneityFadi Jacob, Ryan D Salinas, Daniel Y Zhang, et al.
Pageof 52